ICCM IceCure Medical Ltd.
Price Chart
Executive Summary
IceCure Medical announced a 1-for-30 reverse share split effective June 4, 2026, to regain compliance with Nasdaq's $1.00 minimum bid price requirement. The split reduces outstanding shares from ~84.2M to ~2.8M but does not change fundamental value, serving as a technical measure to avoid delisting. Combined with recent equity raises and a history of poor stock performance, the action signals ongoing financial distress.
Actionable Insight
The reverse split is a technical fix to maintain listing, not a catalyst for recovery. Given the company's pre-revenue status, repeated dilution, and negative historical stock performance, further capital raises or adverse clinical/regulatory news could drive additional downside. Monitor for compliance status and any financing announcements post-split.
Key Facts
- 1-for-30 reverse share split approved by board, effective June 4, 2026.
- Outstanding shares reduce from 84,201,034 to approximately 2,806,701.
- Purpose is to meet Nasdaq $1.00 minimum bid price; cure deadline is November 9, 2026.
- Company has a small market cap of ~$16M and pre-revenue status.
- Prior 424B5 equity offer for $4.34M filed 21 days ago, signaling ongoing cash needs.
Financial Impact
No direct financial impact; reverse split does not affect cash or operations.
Risk Factors
- Potential failure to maintain Nasdaq compliance if stock price falls again after split.
- Ongoing cash burn may require additional dilutive financing.
- Reverse splits often signal distress and can lead to further selling pressure.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-063815 |
| Document: ea029311601ex99-1.htm | 0001213900-26-063815 |
| Document: 0001213900-26-063815-index-headers.html | 0001213900-26-063815 |
| Document: 0001213900-26-063815-index.html | 0001213900-26-063815 |
| Document: 0001213900-26-063815.txt | 0001213900-26-063815 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
12d ago
|
6-K
| $4.17 $4.55 | ▼ −9.21% | ▼ −9.90% | $2.39 (+42.69%) |
|
May 12, 2026
4w ago
|
424B5
| $0.2370 $0.2370 | · 0.00% | ▼ −0.00% | $2.39 (−908.44%) |
|
May 12, 2026
4w ago
|
6-K
| $0.2400 $0.2370 | ▼ −1.25% | ▼ −1.83% | $2.39 (+895.83%) |
|
May 6, 2026
5w ago
|
6-K
| $7.50 $7.20 | ▲ +4.00% | ▲ +4.83% | $2.39 (+68.13%) |
|
Apr 21, 2026
7w ago
|
6-K
| $0.3500 $0.3570 | ▲ +2.00% | ▲ +0.98% | $2.39 (+582.86%) |
|
Apr 13, 2026
9w ago
|
EFFECT
| $0.3370 $0.3550 | ▲ +5.34% | ▲ +4.13% | $2.39 (+609.20%) |
|
Apr 1, 2026
10w ago
|
F-1
| $0.3000 $0.3020 | ▲ +0.67% | ▲ +0.19% | $2.39 (+696.67%) |
|
Mar 25, 2026
11w ago
|
EFFECT
| $0.5880 $0.3900 | ▼ −33.67% | ▼ −31.90% | $2.39 (+306.46%) |
|
Mar 24, 2026
11w ago
|
EFFECT
| $0.6090 $0.5880 | ▼ −3.45% | ▼ −4.01% | $2.39 (+292.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access